> Wyeth Pharmaceuticals and Siemens Medical Solutions have signed an agreement to utilize Siemens' research imaging agent in Wyeth's clinical studies of new therapies in development for Alzheimer's disease. Release
> Perrigo Company is acquiring the generic products of Glades Pharmaceuticals for $56 million. Release
> BioCryst Pharmaceuticals and Shionogi have inked a license agreement to develop and commercialize BioCryst's lead influenza neuraminidase inhibitor, peramivir, in Japan for the treatment of seasonal and potentially life-threatening human influenza. Release
And Finally... Physicians and cancer survivors say political views are clouding the HPV vaccine debate. Report